Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Revenue of Inspire Medical Systems, Inc. (INSP)
Revenue in 2023 (TTM): $624.8 M
According to Inspire Medical Systems, Inc.'s latest financial reports the company's current revenue (TTM) is $624.8 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Inspire Medical Systems, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $624.8 M | $528.22 M | $-17,060,000 | $-19,906,000 | $-21,153,000 |
| 2022 | $407.86 M | $341.74 M | $-39,693,000 | $-44,268,000 | $-44,881,000 |
| 2021 | $233.39 M | $200.12 M | $-38,624,000 | $-41,970,000 | $-42,042,000 |
| 2020 | $115.38 M | $97.76 M | $-53,159,000 | $-57,088,000 | $-57,203,000 |
| 2019 | $82.05 M | $68.41 M | $-29,685,000 | $-33,203,000 | $-33,243,000 |
| 2018 | $50.59 M | $40.54 M | $-18,131,000 | $-21,828,000 | $-21,828,000 |
| 2017 | $28.57 M | $22.55 M | $-15,473,000 | $-17,511,000 | $-17,511,000 |
| 2016 | $16.43 M | $12.52 M | $-17,122,000 | $-18,528,000 | $-18,528,000 |
| 2015 | $8.01 M | $5.2 M | $-19,653,000 | $-21,337,000 | $-21,337,000 |